Literature DB >> 9692170

Phenytoin in the treatment of Buruli ulcer.

O Adjei1, M R Evans, A Asiedu.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9692170     DOI： 10.1016/s0035-9203(98)90977-4

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  7 in total

1.  In vitro killing of Mycobacterium ulcerans by acidified nitrite.

Authors:  R Phillips; S Kuijper; N Benjamin; M Wansbrough-Jones; M Wilks; A H J Kolk
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

2.  Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxides.

Authors:  R Phillips; O Adjei; S Lucas; N Benjamin; M Wansbrough-Jones
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

3.  New anti-tuberculosis agents amongst known drugs.

Authors:  Kathryn E A Lougheed; Debra L Taylor; Simon A Osborne; Justin S Bryans; Roger S Buxton
Journal:  Tuberculosis (Edinb)       Date:  2009-08-20       Impact factor: 3.131

4.  Screening of antifungal azole drugs and agrochemicals with an adapted alamarBlue-based assay demonstrates antibacterial activity of croconazole against Mycobacterium ulcerans.

Authors:  Nicole Scherr; Katharina Röltgen; Matthias Witschel; Gerd Pluschke
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

5.  In Vitro Susceptibility of Mycobacterium ulcerans Isolates to Selected Antimicrobials.

Authors:  Enid Owusu; Mercy J Newman; Kwesi K Addo; Phyllis Addo
Journal:  Can J Infect Dis Med Microbiol       Date:  2017-03-14       Impact factor: 2.471

Review 6.  Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease).

Authors:  Rie R Yotsu; Marty Richardson; Norihisa Ishii
Journal:  Cochrane Database Syst Rev       Date:  2018-08-23

7.  In vitro antibacterial activity and in vivo efficacy of hydrated clays on Mycobacterium ulcerans growth.

Authors:  Sarojini Adusumilli; Shelley E Haydel
Journal:  BMC Complement Altern Med       Date:  2016-01-30       Impact factor: 3.659
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.